Gyre Therapeutics, Inc.GYRENASDAQ
Loading
Debt to Assets Over TimeCompressed
Percentile Rank29
3Y CAGR-7.9%
5Y CAGR-20.1%
Year-over-Year Change
Debt-to-assets ratio
3Y CAGR
-7.9%/yr
Annual compound
5Y CAGR
-20.1%/yr
Recent acceleration
Percentile
P29
Within normal range
vs 5Y Ago
0.3x
Contraction
Streak
1 yr
Consecutive declineCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 0.01 | -55.6% |
| 2024 | 0.01 | +263.1% |
| 2023 | 0.00 | -51.5% |
| 2022 | 0.01 | -83.1% |
| 2021 | 0.04 | +147.2% |
| 2020 | 0.02 | -5.2% |
| 2019 | 0.02 | - |
| 2018 | 0.00 | -100.0% |
| 2017 | 0.13 | -74.7% |
| 2016 | 0.51 | - |